A mouse model of hypercholesterolemia-induced erectile dysfunction

Journal of Sexual Medicine

Volumn 4, Issue 4 I, 2007, Pages 898-907

  Xie, Donghua ^a   Odronic, Shelly I ^a   Wu, Feihua ^a   Pippen, Anne M ^a   Donatucci, Craig F ^a   Annex, Brian H ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelium; Impotence; Nitric oxide synthase; Penis; Vascular smooth muscle

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; COLLAGEN; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; SERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CAPILLARY DENSITY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; CORPUS CAVERNOSUM; CORRELATION ANALYSIS; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; ENZYME PHOSPHORYLATION; ERECTILE DYSFUNCTION; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 34447548638     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2007.00518.x     Document Type: Article

References (40)

1. Lue TF. Erectile dysfunction. N Engl J Med 2000; 342: 1802-13.
2. Wei M, Macera CA, Davis DR, Hornung CA, Nankin HR, Blair SN. Total cholesterol and high-density lipoprotein cholesterol as important predictors of erectile dysfunction [see comments]. Am J Epidemiol 1994; 140: 930-7.
3. Mulhall J, Teloken P, Brock G, Kim E. Obesity, dyslipidemias and erectile dysfunction: A report of a subcommittee of the sexual medicine society of North America. J Sex Med 2006; 3: 778-86.
4. Laumann EO, West S, Glasser D, Carson C, Rosen R, Kang JH. Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: From the male attitudes regarding sexual health survey. J Sex Med 2007; 4: 57-65.
5. Gimbrone MA Jr. Vascular endothelium: An integrator of pathophysiologic stimuli in atherosclerosis. Am J Cardiol 1995; 75: 67B-70B.
6. Azadzoi KM, Goldstein I. Erectile dysfunction due to atherosclerotic vascular disease: The development of an animal model. J Urol 1992; 147: 1675-81.
7. Kim JH, Klyachkin ML, Svendsen E, Davies MG, Hagen PO, Carson CC 3rd. Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction. J Urol 1994; 151: 198-205.
8. Nehra A, Azadzoi KM, Moreland RB, Pabby A, Siroky MB, Krane RJ, Goldstein I, Udelson D. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. J Urol 1998; 159: 2229-36.
9. Azadzoi KM, Saenz de Tejada I. Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol 1991; 146: 238-40.
10. Bakircioglu ME, Hsu K, El-Sakka A, Sievert KD, Lin CS, Lue TF. Effect of a Chinese herbal medicine mixture on a rat model of hypercholesterolemic erectile dysfunction. J Urol 2000; 164: 1798-1801.
11. Park K, Son H, Kim SW, Paick JS. Initial validation of a novel rat model of vasculogenic erectile dysfunction with generalized atherosclerosis. Int J Impot Res 2005; 17: 424-30.
12. Ryu JK, Shin HY, Song SU, Oh SM, Piao S, Han JY, Park KW, Suh JK. Downregulation of angiogenic factors and their downstream target molecules affects the deterioration of erectile function in a rat model of hypercholesterolemia. Urology 2006; 67: 1329-34.
13. -/- mice. Circulation 1999; 99: 3188-98.
14. Greenow K, Pearce NJ, Ramji DP. The key role of apolipoprotein E in atherosclerosis. J Mol Med 2005; 83: 329-42.
15. Jawien J, Nastalek P, Korbut R. Mouse models of experimental atherosclerosis. J Physiol Pharmacol 2004; 55: 503-17.
16. Behr-Roussel D, Darblade B, Oudot A, Compagnie S, Bernabe J, Alexandre L, Giuliano F. Erectile dysfunction in hypercholesterolemic. Atherosclerotic apolipoprotein E knockout mice. J Sex Med 2006; 3: 596-603.
17. Henry GD, Byrne RR, Huuyh TTT, Abraham V, Annex BH, Hagen PO, Donatucci CF. Intracavernosal injections of vascular endothelial growth factor protects endothelial-dependant corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit: A preliminary study. Int J Impotence Res 2000; 12: 334-9.
18. Byrne RR, Henry GD, Hunyh TTT, Pippen AM, Annex BH, Hagen PO, Donatucci CF. Vascular endothelial growth factor restores corporal smooth muscle response to nitric oxide. J Urol 2001; 165: 1310-5.
19. Xie D, Thompson MA, Pippen AM, Waters RE, Donatucci CF, Annex BH. Decreases in corporal vascular endothelial growth factor expression precede vasoreactivity changes in cholesterol fed rabbits. J Urol 2005; 173: 1418-22.
20. Xie D, Pippen AM, Odronic SI, Annex BH, Donatucci CF. Intracavernosal basic fibroblast growth factor improves vasoreactivity in the hypercholesterolemic rabbit. J Sex Med 2006; 3: 223-32.
21. Palese MA, Crone JK, Burnett AL. A castrated mouse model of erectile dysfunction. J Androl 2003; 24: 699-703.
22. Xie D, Li Y, Reed EA, Odronic SI, Kontos CD, Annex BH. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia. J Vasc Surg 2006; 44: 166-75.
23. Xie D, Kontos CD, Donatucci CF, Annex BH. Cholesterol feeding reduces vascular endothelial growth factor signaling in rabbit corporal tissues. J Sex Med 2005; 2: 643-40.
24. Azadzoi KM, Goldstein I, Siroky MB, Traish AM, Krane RJ. Saenz de Tejada I. Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol 1998; 160: 2216-22.
25. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
26. Kloner RA, Speakman M. Erectile dysfunction and atherosclerosis. Curr Atheroscler Rep 2002; 4: 397-401.
27. VanTeeffelen JW, Constantinescu AA, Vink H, Spaan JA. Hypercholesterolemia impairs reactive hyperemic vasodilation of 2A but not 3 arterioles in mouse cremaster muscle. Am J Physiol Heart Circ Physiol 2005; 289: H447-54.
28. Matsumoto T, D'uscio LV, Eguchi D, Akiyama M, Smith LA, Katusic ZS. Protective effect of chronic vitamin C treatment on endothelial function of apolipoprotein E-deficient mouse carotid artery. J Pharmacol Exp Ther 2003; 306: 103-8.
29. Azadzoi KM, Krane RJ, Saenz de Tejada I, Goldstein I, Siroky MB. Relative roles of cyclooxygenase and nitric oxide synthase pathways in ischemia-induced increased contraction of cavernosal smooth muscle. J Urol 1999; 161: 1324-8.
30. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995; 75: 191-236.
31. Burnett AL, Calvin DC, Silver RI, Peppas DS, Docimo SG. Immunohistochemical description of nitric oxide synthase isoforms in human clitoris. J Urol 1997; 158: 75-8.
32. Toda N, Ayajiki K, Okamura T. Nitric oxide and penile erectile function. Pharmacol Ther 2005; 106: 233-66.
33. Lin CS, Lue TF. Growth factor therapy and neuronal nitric oxide synthase. Int J Impot Res 2004; 16 (suppl. 1): S38-9.
34. Burnett AL. Novel nitric oxide signaling mechanisms regulate the erectile response. Int J Impot Res 2004; 16 (suppl. 1): S15-9.
35. Musicki B, Kramer MF, Becker RE, Burnett AL. Age-related changes in phosphorylation of endothelial nitric oxide synthase in the rat penis. J Sex Med 2005; 2: 347-55; discussion 355-7.
36. Musicki B, Kramer MF, Becker RE, Burnett AL. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc Natl Acad Sci USA 2005; 102: 11870-5.
37. Ding H, Hashem M, Triggle C. Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: Changes in expression of NADPH oxidase subunits and eNOS. Eur J Pharmacol 2007; 561: 121-8.
38. Wang T, Soker S, Atala A, Siroky MB, Azadzoi KM. Alterations in angiogenic growth factors and neuronal nitric oxide synthase expression in chronic cavernosal ischemia. Int J Impot Res 2004; 16: 403-11.
39. Burnett AL. Phosphodiesterase 5 mechanism and therapeutic applications. Am J Cardiol 2005; 96: 29M-31M.
40. Siroky MB, Azadzoi KM. Vasculogenic erectile dysfunction: Newer therapeutic strategies. J Urol 2003; 170: S24-9; discussion S29-30.